Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...
MyChesCo on MSN37m
Harmony Biosciences Names Adam Zaeske as Chief Commercial OfficerHarmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced the appointment of Adam Zaeske as its new Executive Vice ...
Q1 stock picks updated with new commentary and ratings. See why Apple’s being dropped and 38 new stocks are covered for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback